Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Investment Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

BB Adamant Biotech AG

+ Add to Watchlist

BION:BQ

242.1500 CHF 0.00000.00%

As of 11:35:01 ET on 05/22/2015.

Snapshot for BB Adamant Biotech AG (BION)

Open: - High - Low: - Primary Exchange: Equiduct
Volume: 0 52-Week Range: - Beta vs NBI: 0.5281

ETF Chart for BION

No chart data available.
  • BION:BQ 242.1500
  • 1M
  • 1Y
242.1500
Interactive BION Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BION

BB Adamant Biotech is an investment company.The Company invests in biotech companies that operate in areas that include oncology, cardiovascular diseases, infectious diseases and autoimmune diseases.

Inception Date: Telephone: Tel: +41 44 267 67 00
Managers: DANIEL KOLLER
Web Site: www.bellevue.ch/cms/home/bellevue_asset_management

Fundamentals for BION

NAV -
Assets (M) -
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for BION

No dividends reported

Performance for BION

1-Month -0.00% 1-Year +60.09%
3-Month +4.79% 3-Year -
Year To Date +60.09% 5-Year -
Expense Ratio -

Top Fund Holdings for BION

Filing Date: 03/31/2015
Name Position Value % of Total
Celgene Corp 3,554,298 398,600,000 10.692%
Isis Pharmaceuticals Inc 5,729,426 354,900,000 9.520%
Incyte Corp 3,791,867 338,100,000 9.069%
Gilead Sciences Inc 2,865,596 273,600,000 7.339%
Actelion Ltd 2,402,424 270,500,000 7.256%
Agios Pharmaceuticals Inc 1,849,921 169,700,000 4.552%
Medivation Inc 1,274,706 160,100,000 4.294%
Vertex Pharmaceuticals Inc 1,334,445 153,100,000 4.107%
Radius Health Inc 3,722,140 149,000,000 3.997%
Neurocrine Biosciences Inc 3,201,552 123,700,000 3.318%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil